ClinChoice, a global contract research organization, completed the acquisition of CSI Medical Research, a a regional clinical CRO. Financial terms were not disclosed. "This is an exciting time for ClinChoice, and we are thrilled to welcome the talented CSI team to the ClinChoice family. With their wide-range of highly valuable service offering and seasoned professional team, the acquisition of CSI will further expand our presence in SEA and ANZ, and enhance our capability to well fulfill our clients' need locally and globally," Ling Zhen, ClinChoice Global Chairman and CEO.